For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Essen D-45147

0 studies enrolling now · 13 studies all time

What they study most

Cardiovascular Disease, Chronic Migraine, Coronary Artery Disease (CAD), Diabetes Mellitus, Type 2, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Head and Neck Neoplasms, Hepatocellular Carcinoma, Melanoma, Migraine, Muscular Dystrophy, Duchenne, Primary Peritoneal Cancer

Studies at this site

• A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein — Completed
• Evaluation of Galcanezumab in the Prevention of Chronic Migraine — Completed
• A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) — Completed
• Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study — Completed
• An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes — Completed
• A Study of Tadalafil for Duchenne Muscular Dystrophy — Stopped early
• Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) — Completed
• A Study LY2228820 for Recurrent Ovarian Cancer — Completed
• A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma — Stopped early
• A Study in Participants With Type 2 Diabetes Mellitus — Completed
• A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin — Completed
• Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI) — Stopped early
• A Study for Patients With Head and Neck Cancer — Completed